Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Lutein + Zeaxanthin wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
12 of 13 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
8 of 15 studies with measurable effects showed benefit.
Top outcomes
10mg lutein + 2mg zeaxanthin
With a meal containing fat
Softgels with both lutein and zeaxanthin
500-2000mg daily for lipid effects; 50-500mg for general health
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
3-6 months
4-8 weeks
3-6 months
4-8 weeks
4-8 weeks
30-60 minutes after dose
The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis
The American journal of clinical nutrition (2016) · Meta analysis · n=387569
Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
The Cochrane database of systematic reviews (2023) · Systematic review · n=2445
These studies enroled 11,952 people aged 65 to 75 years and included slightly more women (on average 56% women).
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28
JAMA ophthalmology (2022) · Rct · n=3882
This study included 3882 participants (mean [SD] baseline age, 72.0 [7.7] years; 2240 women [57.7%]) and 6351 eyes.
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
Participants randomised to niacin were more likely to discontinue treatment due to side effects than participants randomised to control group (RR 2.17, 95% CI 1.70 to 2.77; participants = 33,539; studies = 17; I2 = 77%; moderate-quality evidence).
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
Among available LLTs, PCSK9mAbs, inclisiran, CETPi, and niacin significantly decreased Lp(a) levels.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Meta analysis
Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice.
Based on multiple meta-analyses showing significant MPOD increases in both AMD patients and healthy subjects. Effect size modest but consistent across studies. Higher doses may increase carotenodermia risk.
Based on multiple meta-analyses showing HDL increases. Higher doses increase discontinuation rates due to side effects (RR 2.17). Immediate-release forms have better lipid effects but more flushing.
AI-estimated from published studies. Interpret as directional guidance.
Lutein + Zeaxanthin has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For healthy aging, Lutein + Zeaxanthin has a higher relevance score (95 vs 65).
No known interactions between Lutein + Zeaxanthin and Niacin have been documented in our database. However, always consult a healthcare provider before combining supplements.